The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Aim: The primary percutaneous procedure resulted in a significant improvement in the prognosis of myocardial infarction. However, no-reflow phenomenon restrains this benefit of the process. There are studies suggesting that soluble suppression of tumorigenicity (sST2) can be valuable in the diagnosi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Atheroscler Thromb
Prif Awduron: Somuncu, Mustafa Umut, Akgun, Tunahan, Cakır, Mustafa Ozan, Akgul, Ferit, Serbest, Nail Guven, Karakurt, Huseyin, Can, Murat, Demir, Ali Riza
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Japan Atherosclerosis Society 2019
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6845696/
https://ncbi.nlm.nih.gov/pubmed/30996145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.48413
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg